115 related articles for article (PubMed ID: 36215707)
1. Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil.
El Oumeiri B; van de Borne P; Hubesch G; Jespers P; Dewachter L; Stefanidis C; Mc Entee K; Vanden Eynden F
J Basic Clin Physiol Pharmacol; 2022 Nov; 33(6):743-750. PubMed ID: 36215707
[TBL] [Abstract][Full Text] [Related]
2. Preoperative, postoperative and one-year follow-up of N-terminal pro-B-type natriuretic peptide levels in volume overload of aortic regurgitation: comparison with pressure overload of aortic stenosis.
Song BG; Park YH; Kang GH; Chun WJ; Oh JH; Choi JO; Lee SC; Park SW; Oh JK; Sung KI; Park P; Jeon ES
Cardiology; 2010; 116(4):286-91. PubMed ID: 20861629
[TBL] [Abstract][Full Text] [Related]
3. The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation.
El Oumeiri B; van de Borne P; Hubesch G; Herpain A; Annoni F; Jespers P; Stefanidis C; Mc Entee K; Vanden Eynden F
Physiol Rep; 2021 Aug; 9(16):e14988. PubMed ID: 34405966
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide and Soluble ST2 for Heart Failure in Chronic Kidney Disease Patients: A Comparative Analysis.
Ma H; Zhou J; Zhang M; Shen C; Jiang Z; Zhang T; Gao F
Med Sci Monit; 2023 Sep; 29():e940641. PubMed ID: 37667469
[TBL] [Abstract][Full Text] [Related]
5. Effects of the cardiac myosin activator Omecamtiv-mecarbil on severe chronic aortic regurgitation in Wistar rats.
El-Oumeiri B; Mc Entee K; Annoni F; Herpain A; Vanden Eynden F; Jespers P; Van Nooten G; van de Borne P
BMC Cardiovasc Disord; 2018 May; 18(1):99. PubMed ID: 29783950
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of N-terminal pro B-type natriuretic peptide (NT-proBNP) in patients with chronic aortic regurgitation.
Weber M; Hausen M; Arnold R; Moellmann H; Nef H; Elsaesser A; Mitrovic V; Hamm C
Int J Cardiol; 2008 Jul; 127(3):321-7. PubMed ID: 18055041
[TBL] [Abstract][Full Text] [Related]
7. Circulating levels and prognostic value of soluble ST2 in heart failure are less influenced by age than N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T.
Aimo A; Januzzi JL; Vergaro G; Richards AM; Lam CSP; Latini R; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; de Boer RA; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Passino C; Emdin M
Eur J Heart Fail; 2020 Nov; 22(11):2078-2088. PubMed ID: 31919929
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of combined sST2 and NT-proBNP detection for the short-term prognosis of acute organophosphorus pesticide poisoning].
Chen J; Zhu J; Liu XT; Wang L; Qi HN; Ma GY
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2021 Sep; 39(9):671-674. PubMed ID: 34624949
[No Abstract] [Full Text] [Related]
9. [Soluble Suppression of Tumorogenicity 2 Increases Opportunities for Risk Stratification After Acute Heart Failure Decompensation].
Skvortsov AA; Protasov VN; Narusov OY; Koshkina DE; Nasonova SN; Masenko VP; Tereschenko SN
Kardiologiia; 2017 Jan; (1):48-58. PubMed ID: 28290833
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of chronic heart failure by the soluble suppression of tumorigenicity 2 and N-terminal pro-brain natriuretic peptide.
Jin XL; Huang N; Shang H; Zhou MC; Hong Y; Cai WZ; Huang J
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28719009
[TBL] [Abstract][Full Text] [Related]
11. Early changes in N-terminal pro-B-type natriuretic peptide levels after transcatheter aortic valve replacement and its impact on long-term mortality.
Liebetrau C; Gaede L; Kim WK; Arsalan M; Blumenstein JM; Fischer-Rasokat U; Wolter JS; Kriechbaum S; Huber MT; van Linden A; Berkowitsch A; Dörr O; Nef H; Hamm CW; Walther T; Möllmann H
Int J Cardiol; 2018 Aug; 265():40-46. PubMed ID: 29885699
[TBL] [Abstract][Full Text] [Related]
12. Circulating levels and prognostic cut-offs of sST2, hs-cTnT, and NT-proBNP in women vs. men with chronic heart failure.
Vergaro G; Gentile F; Aimo A; Januzzi JL; Richards AM; Lam CSP; de Boer RA; Meems LMG; Latini R; Staszewsky L; Anand IS; Cohn JN; Ueland T; Gullestad L; Aukrust P; Brunner-La Rocca HP; Bayes-Genis A; Lupón J; Yoshihisa A; Takeishi Y; Egstrup M; Gustafsson I; Gaggin HK; Eggers KM; Huber K; Gamble GD; Ling LH; Leong KTG; Yeo PSD; Ong HY; Jaufeerally F; Ng TP; Troughton R; Doughty RN; Devlin G; Lund M; Giannoni A; Passino C; Emdin M
ESC Heart Fail; 2022 Aug; 9(4):2084-2095. PubMed ID: 35510529
[TBL] [Abstract][Full Text] [Related]
13. Combined use of high-sensitivity ST2 and NT-proBNP for predicting major adverse cardiovascular events in coronary heart failure.
Bai J; Han L; Liu H
Ann Palliat Med; 2020 Jul; 9(4):1976-1989. PubMed ID: 32762223
[TBL] [Abstract][Full Text] [Related]
14. Does residual aortic regurgitation after transcatheter aortic valve implantation increase mortality in all patients? The importance of baseline natriuretic peptides.
Borz B; Durand E; Godin M; Tron C; Canville A; Hauville C; Bauer F; Cribier A; Eltchaninoff H
Int J Cardiol; 2014 May; 173(3):436-40. PubMed ID: 24679693
[TBL] [Abstract][Full Text] [Related]
15. Association of NT-proBNP with severity of heart valve disease in a medical patient population presenting with acute dyspnea or peripheral edema.
Behnes M; Lang S; Breithardt OA; Kaden JJ; Haghi D; Ahmad-Nejad P; Elmas E; Wolpert C; Borggrefe M; Neumaier M; Brueckmann M
J Heart Valve Dis; 2008 Sep; 17(5):557-65. PubMed ID: 18980090
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of NT-proBNP in the assessment of patients with aortic or mitral regurgitation.
Petracca F; Affuso F; Di Conza P; Micillo F; Castellano G; Guardasole V; Scopacasa F; Saccà L; Fazio S
J Cardiovasc Med (Hagerstown); 2009 Dec; 10(12):928-32. PubMed ID: 19606057
[TBL] [Abstract][Full Text] [Related]
17. Superior prognostic value of soluble suppression of tumorigenicity 2 for the short-term mortality of maintenance hemodialysis patients compared with NT-proBNP: a prospective cohort study.
Wang Z; Chen Z; Yu H; Ma X; Zhang C; Qu B; Zhang W; Chen X
Ren Fail; 2020 Nov; 42(1):523-530. PubMed ID: 32460670
[No Abstract] [Full Text] [Related]
18. [Not Available].
Protasov VN; Narusov OY; Skvortsov AA; Protasova DE; Kuznetsova TV; Petrukhina AA; Masenko VP; Tereshchenko SN
Kardiologiia; 2019 Jan; 59(1S):53-64. PubMed ID: 30706839
[TBL] [Abstract][Full Text] [Related]
19. Comparison of predictive value of NT-proBNP, sST2 and MMPs in heart failure patients with different ejection fractions.
Pan W; Yang D; Yu P; Yu H
BMC Cardiovasc Disord; 2020 Apr; 20(1):208. PubMed ID: 32354356
[TBL] [Abstract][Full Text] [Related]
20. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease.
Weber M; Arnold R; Rau M; Elsaesser A; Brandt R; Mitrovic V; Hamm C
Eur Heart J; 2005 May; 26(10):1023-30. PubMed ID: 15781428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
